Showing results (1971-1980 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|January 7, 2004
The antiangiogenic agent Neovastat (AE-941) stimulates tissue plasminogen activator activityDenis Gingras, Dominique Labelle, Carine Nyalendo, et al.Investigational New Drugs|January 7, 2004
Population pharmacokinetics of sibrotuzumab, a novel therapeutic monoclonal antibody, in cancer patientsC Kloft, E-U Graefe, P Tanswell, et al.Investigational New Drugs|January 7, 2004
Treatment of AIDS related non-Hodgkin's lymphoma with combination mitoguazone dihydrochloride and low dose CHOP chemotherapy: results of a phase II studyAnil Tulpule, Byron M Espina, A B Pedro Santabarbara, et al.Investigational New Drugs|January 7, 2004
A phase II study of 9-nitro-camptothecin in patients with previously treated metastatic breast cancerKathy D Miller, Sharon E Soule, LaTrice G Haney, et al.Investigational New Drugs|October 28, 2003
Phase II trial and pharmacokinetic study of thalidomide in patients with metastatic colorectal cancerLissandra Dal Lago, Marc F Richter, Anna I Cancela, et al.Investigational New Drugs|October 31, 2003
Effect of novel benzoylphenylurea derivatives on DNA polymerase alpha activity using the synthesome-based in vitro model systemWaleed Abdel-Aziz, Robert Hickey, Martin Edelman, et al.Investigational New Drugs|October 31, 2003
A study of a different dose-intense infusion schedule of phenylacetate in patients with recurrent primary brain tumors consortium reportSusan M Chang, John G Kuhn, H Ian Robins, et al.Investigational New Drugs|October 31, 2003
A randomized phase II evaluation of bryostatin-1 (NSC #339555) in persistent or recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group StudyDeborah K Armstrong, John A Blessing, Janet Rader, et al.Investigational New Drugs|January 24, 2004
Weekly gemcitabine for the treatment of biliary tract and gallbladder cancerNikolas Tsavaris, Christos Kosmas, Panagiotis Gouveris, et al.Investigational New Drugs|May 4, 2004
Pharmacogenetics of tipifarnib (R115777) transport and metabolism in cancer patientsAlex Sparreboom, Sharon Marsh, Ron H J Mathijssen, et al.Pageof 372